We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Phillips 66
PSX
$81.4B
| $9.22M | 0.06% |
106,230
+12,163
| +13% | +$1.19M |
|
|
XLRN
277
DELISTED
Acceleron Pharma
XLRN
| $9.19M | 0.06% |
215,530
-76,700
| -26% | -$3.83M |
|
278
Las Vegas Sands
LVS
$29.6B
| $9.18M | 0.06% |
178,455
-323,012
| -64% | -$17.5M |
|
279
Universal Health Services
UHS
$10.5B
| $9.18M | 0.06% |
78,364
+24,586
| +46% | +$3.09M |
|
280
Brown & Brown
BRO
$23.9B
| $9.16M | 0.06% |
339,666
-17,200
| -5% | -$486K |
|
281
Tesla
TSLA
$1.3T
| $9.1M | 0.06% |
420,630
+225,270
| +115% | +$4.85M |
|
282
CMS Energy
CMS
$22.3B
| $8.95M | 0.06% |
180,006
-9,622
| -5% | -$486K |
|
283
NetEase
NTES
$84.7B
| $8.94M | 0.06% |
71,850
+22,285
| +45% | +$1.01M |
|
284
PNC Financial Services
PNC
$101B
| $8.83M | 0.06% |
74,847
+890
| +1% | +$114K |
|
285
Nucor
NUE
$62.1B
| $8.73M | 0.06% |
165,656
-25,531
| -13% | -$1.51M |
|
286
United Therapeutics
UTHR
$23.1B
| $8.72M | 0.06% |
82,628
+7,400
| +10% | +$858K |
|
287
Stratasys
SSYS
$774M
| $8.71M | 0.06% |
486,500
+27,347
| +6% | +$572K |
|
288
Emcor
EME
$36B
| $8.67M | 0.06% |
145,280
-20,852
| -13% | -$1.44M |
|
289
Norfolk Southern
NSC
$75.1B
| $8.48M | 0.06% |
56,175
-2,787
| -5% | -$458K |
|
290
MDU Resources
MDU
$4.32B
| $8.37M | 0.06% |
943,008
-86,153
| -8% | -$841K |
|
291
Labcorp
LH
$25.9B
| $8.31M | 0.06% |
77,570
-55,124
| -42% | -$7.38M |
|
292
Capital One
COF
$134B
| $8.29M | 0.05% |
109,063
-8,496
| -7% | -$736K |
|
293
McCormick & Company Non-Voting
MKC
$14.2B
| $8.23M | 0.05% |
116,778
-60,084
| -34% | -$4.31M |
|
294
Synopsys
SNPS
$79.7B
| $8.12M | 0.05% |
96,960
-55,315
| -36% | -$4.91M |
|
295
Ferrari
RACE
$72.5B
| $7.97M | 0.05% |
80,261
-834
| -1% | -$93.6K |
|
296
Vale
VALE
$62.6B
| $7.95M | 0.05% |
612,031
-198,178
| -24% | -$2.83M |
|
297
Sempra
SRE
$54.8B
| $7.94M | 0.05% |
146,086
+11,718
| +9% | +$668K |
|
298
Citizens Financial Group
CFG
$30.6B
| $7.94M | 0.05% |
266,577
-28,050
| -10% | -$983K |
|
299
T. Rowe Price
TROW
$24.3B
| $7.91M | 0.05% |
85,720
-17,670
| -17% | -$1.72M |
|
300
AES
AES
$10.5B
| $7.89M | 0.05% |
546,683
+77,309
| +16% | +$1.16M |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.